Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
novartis
4
×
san francisco blog main
san francisco top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
abbvie
akcea therapeutics
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
gene therapy
glaxosmithkline
graybug vision
medical devices
medullary thyroid cancer
new york blog main
new york top stories
non-hodgkin lymphoma
nonalcoholic steatohepatitis
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
What
cancer
4
×
bio
investors
ipo
roundup
abbvie’s
address
ahead
allogene
approval
approves
biofourmis
blood
blueprint
broader
bucks
carries
celebrate
certain
chance
company
corner
crispr
day
days
designed
detect
developing
diversity
drug
fda
files
firms
forward
genetic
grail
holiday
hot
immunotherapy
intended
Language
unset
Current search:
novartis
×
cancer
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
